IN

Integrated Biopharma IncOOTC INBP Stock Report

Last reporting period 31 Mar, 2024

Updated 18 Sep, 2024

Last price

Market cap $B

0.007

Micro

Exchange

OOTC - OTC

INBP Stock Analysis

IN

Uncovered

Integrated Biopharma Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

4/100

Low score

Market cap $B

0.007

Dividend yield

Shares outstanding

29.95 B

Integrated BioPharma, Inc. engages in the manufacturing, distributing, marketing, and sales of vitamins, nutritional supplements, and herbal products. The company is headquartered in Hillside, New Jersey and currently employs 147 full-time employees. The Company’s business segments include Contract Manufacturing operated by Manhattan Drug Company, Inc. (MDC), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers and Other Nutraceutical Businesses, which includes the operations of AgroLabs, Inc. (AgroLabs), which distributed healthful nutritional products for sale through major mass market, grocery and drug and vitamin retailers under brands: Peaceful Sleep, and Wheatgrass and other products introduced into the market using the AgroLabs name; The Vitamin Factory, IHT Health Products, Inc. (IHT), MDC Warehousing and Distribution, Inc., and Chem International, Inc. The Company’s customers are located in the United States and Luxembourg.

View Section: Eyestock Rating